<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Mesothelioma Journal Articles &#187; Oxaliplatine</title>
	<atom:link href="http://www.mesothelioma-line.com/articles/category/oxaliplatine/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.mesothelioma-line.com/articles</link>
	<description>Journal Articles on Mesothelioma: Cancer Information for Patients and Families</description>
	<lastBuildDate>Wed, 15 Jun 2011 19:57:18 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications</title>
		<link>http://www.mesothelioma-line.com/articles/2008/01/31/treatment-of-peritoneal-carcinomatosis-with-surgery-and-hyperthermic-peroperative-intraperitoneal-chemotherapy-hipec-new-aspects-and-validated-indications/</link>
		<comments>http://www.mesothelioma-line.com/articles/2008/01/31/treatment-of-peritoneal-carcinomatosis-with-surgery-and-hyperthermic-peroperative-intraperitoneal-chemotherapy-hipec-new-aspects-and-validated-indications/#comments</comments>
		<pubDate>Thu, 31 Jan 2008 23:07:48 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Intraperitoneal Chemotherapy]]></category>
		<category><![CDATA[Oxaliplatine]]></category>
		<category><![CDATA[Peritoneal (Abdominal Mesothelioma)]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/2008/01/31/treatment-of-peritoneal-carcinomatosis-with-surgery-and-hyperthermic-peroperative-intraperitoneal-chemotherapy-hipec-new-aspects-and-validated-indications/</guid>
		<description><![CDATA[Bulletin du Cancer. 2008 Jan 30;95(1):141-145. [Link] Eveno C, Dagois S, Guillot E, Gornet JM, Pocard M. Département médicochirurgical de pathologie digestive, Hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris. Abstract Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) is now an entire part of treatment of peritoneal dissemination of colorectal malignancy, and it&#8217;s possible to hope prolonged survival. [...]]]></description>
			<content:encoded><![CDATA[<p><em>Bulletin du Cancer</em>. 2008 Jan 30;95(1):141-145. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18230580?dopt=AbstractPlus">Link</a>]</p>
<p><strong>Eveno C, Dagois S, Guillot E, Gornet JM, Pocard M.</strong></p>
<p>Département médicochirurgical de pathologie digestive, Hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris.</p>
<h3 class="abstract">Abstract</h3>
<p>Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) is now an entire part of treatment of peritoneal dissemination of colorectal malignancy, and it&#8217;s possible to hope prolonged survival. This treatment is more and more codified. Four indications are recognized by some tree national evaluation committees : the French ANAES, the British NICE and the Canadian CEPO : colorectal carcinoma, carcinoma of the appendix, pseudomyxoma peritonei and mesothelioma. Last big published series results show a decrease of morbidity and mortality and interest of using new drugs like oxaliplatine. Indications have to be more homogeneous and based on evidences.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2008/01/31/treatment-of-peritoneal-carcinomatosis-with-surgery-and-hyperthermic-peroperative-intraperitoneal-chemotherapy-hipec-new-aspects-and-validated-indications/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

